Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-termmal nucleophile (Nin) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by she compounds described. For example, the chymotrypsinlike activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.
包括含杂原子的三元环的肽基化合物能有效地、选择性地抑制 N-三卤代亲核物(Nin)水解酶的特定活性。具有多种活性的 Ntn 的活性可受到所述化合物的不同抑制。例如,本发明化合物可选择性地抑制 20S 蛋白酶体的糜蛋白酶样活性。肽基化合物包括环氧化物或氮丙啶,以及 N 端的官能化。除其他治疗作用外,肽基化合物还具有抗炎和抑制细胞增殖的作用。
Calcium-promoted hydrolysis of N-acylureas allows mild release of peptides anchored with the Dpr(Phoc) linker to hydrophilic resins
作者:Robert Pascal、Régine Soda
DOI:10.1016/s0040-4039(97)00973-8
日期:1997.6
Calcium chloride is an efficient additive for promoting the release of short peptide models anchored with Dpr(Phoc) linker to hydrophilic solid-phase synthesis supports. It was shown to induce a moderate to marked (especially for C-terminal proline peptides) increase in the rate of alkaline hydrolytic cleavage, without epimerization at the C-terminal residue, while substantially reducing the hydroxide ion concentration. Base-promoted side-reactions are therefore expected to be slowed down. (C) 1997 Elsevier Science Ltd.
Compounds For Enzyme Inhibition
申请人:Smyth S. Mark
公开号:US20080090785A1
公开(公告)日:2008-04-17
Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsinlike activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.